Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication

17 patients with severe digoxin intoxication were successfully treated with 320 to 480 mg Fab fragments of digoxin-specific IgG from sheep. The infusion period ranged between 0.5 and 7 h. Serum and urine concentrations of digoxin bound to Fab fragments, and in 11 cases unbound Fab fragments in serum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical pharmacology 1986-01, Vol.30 (5), p.527-533
Hauptverfasser: SCHAUMANN, W, KAUFMANN, B, NEUBERT, P, SMOLARZ, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 533
container_issue 5
container_start_page 527
container_title European journal of clinical pharmacology
container_volume 30
creator SCHAUMANN, W
KAUFMANN, B
NEUBERT, P
SMOLARZ, A
description 17 patients with severe digoxin intoxication were successfully treated with 320 to 480 mg Fab fragments of digoxin-specific IgG from sheep. The infusion period ranged between 0.5 and 7 h. Serum and urine concentrations of digoxin bound to Fab fragments, and in 11 cases unbound Fab fragments in serum, were determined during and after the infusion. The renal clearance of bound digoxin and therefore of the antibody was 13.6 ml/min. The median extrarenal clearance of the Fab fragments was 10.9 ml/min. The half-life of the serum concentrations starting at 12 h was 14.3 h, and the value was increased to 25.4 h when regression began at 24 h; the corresponding apparent distribution volumes were 25.9 and 541. These figures exceed the volume of the extracellular space and suggest intracellular penetration of the Fab fragments. The dosage of the antibody should be sufficiently high to bind digoxin in the most severe cases of poisoning. The maximum serum concentrations of bound antibody were 30 mg/l after 3 h and 20 mg/l after 5 h. A loading dose of 160 mg followed by an infusion of 0.5 mg/min was sufficient to absorb digoxin re-diffusing into the serum during the first 8 h. In some cases free digoxin reappeared in the serum 8-12 h after beginning the treatment. This might be prevented by infusing a further ampoule at a rate of 0.1 mg/min or less.
doi_str_mv 10.1007/BF00542410
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_BF00542410</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3758140</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-7b4ee269a7b3990c9e739b99013b1c9d59e7deea98b2c2330a088d27df3dad8f3</originalsourceid><addsrcrecordid>eNpNkMtOwzAQRS0EKqWwYY-UBSukwEyc1PESKgqISmxgHfkxaY3apIpdHn-P-6AgWZqrOcezuIydI1wjgLi5GwMUeZYjHLA-5jxLEXI8ZH0AjulQCjhmJ96_A2AhgfdYj4uixBz6bPXsGgrO-KStkzCjpFY6qTs1XVATNkvrpu2XaxLVBKdb68jHaNdEt6sYfnl8SxXc5tunC7PE0wd19I-HOE1U2uaUHdVq7ulsNwfsbXz_OnpMJy8PT6PbSWo4YkiFzomyoVRCcynBSBJc6piQazTSFnFhiZQsdWYyzkFBWdpM2JpbZcuaD9jV9q7pWu87qqtl5xaq-64QqnV11V91Ub7YysuVXpDdq7uuIr_cceWNmseSGuP8XitFmWEh-A9toHdo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication</title><source>MEDLINE</source><source>SpringerLink (Online service)</source><creator>SCHAUMANN, W ; KAUFMANN, B ; NEUBERT, P ; SMOLARZ, A</creator><creatorcontrib>SCHAUMANN, W ; KAUFMANN, B ; NEUBERT, P ; SMOLARZ, A</creatorcontrib><description>17 patients with severe digoxin intoxication were successfully treated with 320 to 480 mg Fab fragments of digoxin-specific IgG from sheep. The infusion period ranged between 0.5 and 7 h. Serum and urine concentrations of digoxin bound to Fab fragments, and in 11 cases unbound Fab fragments in serum, were determined during and after the infusion. The renal clearance of bound digoxin and therefore of the antibody was 13.6 ml/min. The median extrarenal clearance of the Fab fragments was 10.9 ml/min. The half-life of the serum concentrations starting at 12 h was 14.3 h, and the value was increased to 25.4 h when regression began at 24 h; the corresponding apparent distribution volumes were 25.9 and 541. These figures exceed the volume of the extracellular space and suggest intracellular penetration of the Fab fragments. The dosage of the antibody should be sufficiently high to bind digoxin in the most severe cases of poisoning. The maximum serum concentrations of bound antibody were 30 mg/l after 3 h and 20 mg/l after 5 h. A loading dose of 160 mg followed by an infusion of 0.5 mg/min was sufficient to absorb digoxin re-diffusing into the serum during the first 8 h. In some cases free digoxin reappeared in the serum 8-12 h after beginning the treatment. This might be prevented by infusing a further ampoule at a rate of 0.1 mg/min or less.</description><identifier>ISSN: 0031-6970</identifier><identifier>EISSN: 1432-1041</identifier><identifier>DOI: 10.1007/BF00542410</identifier><identifier>PMID: 3758140</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adolescent ; Adult ; Aged ; Animals ; Antigen-Antibody Reactions ; Biological and medical sciences ; Creatinine - blood ; Digoxin - immunology ; Digoxin - poisoning ; Digoxin - urine ; Drug intoxications. Doping ; Female ; Humans ; Immunoglobulin Fab Fragments - immunology ; Kinetics ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Protein Binding ; Sheep</subject><ispartof>European journal of clinical pharmacology, 1986-01, Vol.30 (5), p.527-533</ispartof><rights>1986 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-7b4ee269a7b3990c9e739b99013b1c9d59e7deea98b2c2330a088d27df3dad8f3</citedby><cites>FETCH-LOGICAL-c311t-7b4ee269a7b3990c9e739b99013b1c9d59e7deea98b2c2330a088d27df3dad8f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8782157$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3758140$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHAUMANN, W</creatorcontrib><creatorcontrib>KAUFMANN, B</creatorcontrib><creatorcontrib>NEUBERT, P</creatorcontrib><creatorcontrib>SMOLARZ, A</creatorcontrib><title>Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication</title><title>European journal of clinical pharmacology</title><addtitle>Eur J Clin Pharmacol</addtitle><description>17 patients with severe digoxin intoxication were successfully treated with 320 to 480 mg Fab fragments of digoxin-specific IgG from sheep. The infusion period ranged between 0.5 and 7 h. Serum and urine concentrations of digoxin bound to Fab fragments, and in 11 cases unbound Fab fragments in serum, were determined during and after the infusion. The renal clearance of bound digoxin and therefore of the antibody was 13.6 ml/min. The median extrarenal clearance of the Fab fragments was 10.9 ml/min. The half-life of the serum concentrations starting at 12 h was 14.3 h, and the value was increased to 25.4 h when regression began at 24 h; the corresponding apparent distribution volumes were 25.9 and 541. These figures exceed the volume of the extracellular space and suggest intracellular penetration of the Fab fragments. The dosage of the antibody should be sufficiently high to bind digoxin in the most severe cases of poisoning. The maximum serum concentrations of bound antibody were 30 mg/l after 3 h and 20 mg/l after 5 h. A loading dose of 160 mg followed by an infusion of 0.5 mg/min was sufficient to absorb digoxin re-diffusing into the serum during the first 8 h. In some cases free digoxin reappeared in the serum 8-12 h after beginning the treatment. This might be prevented by infusing a further ampoule at a rate of 0.1 mg/min or less.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Animals</subject><subject>Antigen-Antibody Reactions</subject><subject>Biological and medical sciences</subject><subject>Creatinine - blood</subject><subject>Digoxin - immunology</subject><subject>Digoxin - poisoning</subject><subject>Digoxin - urine</subject><subject>Drug intoxications. Doping</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin Fab Fragments - immunology</subject><subject>Kinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Binding</subject><subject>Sheep</subject><issn>0031-6970</issn><issn>1432-1041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMtOwzAQRS0EKqWwYY-UBSukwEyc1PESKgqISmxgHfkxaY3apIpdHn-P-6AgWZqrOcezuIydI1wjgLi5GwMUeZYjHLA-5jxLEXI8ZH0AjulQCjhmJ96_A2AhgfdYj4uixBz6bPXsGgrO-KStkzCjpFY6qTs1XVATNkvrpu2XaxLVBKdb68jHaNdEt6sYfnl8SxXc5tunC7PE0wd19I-HOE1U2uaUHdVq7ulsNwfsbXz_OnpMJy8PT6PbSWo4YkiFzomyoVRCcynBSBJc6piQazTSFnFhiZQsdWYyzkFBWdpM2JpbZcuaD9jV9q7pWu87qqtl5xaq-64QqnV11V91Ub7YysuVXpDdq7uuIr_cceWNmseSGuP8XitFmWEh-A9toHdo</recordid><startdate>19860101</startdate><enddate>19860101</enddate><creator>SCHAUMANN, W</creator><creator>KAUFMANN, B</creator><creator>NEUBERT, P</creator><creator>SMOLARZ, A</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19860101</creationdate><title>Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication</title><author>SCHAUMANN, W ; KAUFMANN, B ; NEUBERT, P ; SMOLARZ, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-7b4ee269a7b3990c9e739b99013b1c9d59e7deea98b2c2330a088d27df3dad8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Animals</topic><topic>Antigen-Antibody Reactions</topic><topic>Biological and medical sciences</topic><topic>Creatinine - blood</topic><topic>Digoxin - immunology</topic><topic>Digoxin - poisoning</topic><topic>Digoxin - urine</topic><topic>Drug intoxications. Doping</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin Fab Fragments - immunology</topic><topic>Kinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Binding</topic><topic>Sheep</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHAUMANN, W</creatorcontrib><creatorcontrib>KAUFMANN, B</creatorcontrib><creatorcontrib>NEUBERT, P</creatorcontrib><creatorcontrib>SMOLARZ, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>European journal of clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHAUMANN, W</au><au>KAUFMANN, B</au><au>NEUBERT, P</au><au>SMOLARZ, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication</atitle><jtitle>European journal of clinical pharmacology</jtitle><addtitle>Eur J Clin Pharmacol</addtitle><date>1986-01-01</date><risdate>1986</risdate><volume>30</volume><issue>5</issue><spage>527</spage><epage>533</epage><pages>527-533</pages><issn>0031-6970</issn><eissn>1432-1041</eissn><abstract>17 patients with severe digoxin intoxication were successfully treated with 320 to 480 mg Fab fragments of digoxin-specific IgG from sheep. The infusion period ranged between 0.5 and 7 h. Serum and urine concentrations of digoxin bound to Fab fragments, and in 11 cases unbound Fab fragments in serum, were determined during and after the infusion. The renal clearance of bound digoxin and therefore of the antibody was 13.6 ml/min. The median extrarenal clearance of the Fab fragments was 10.9 ml/min. The half-life of the serum concentrations starting at 12 h was 14.3 h, and the value was increased to 25.4 h when regression began at 24 h; the corresponding apparent distribution volumes were 25.9 and 541. These figures exceed the volume of the extracellular space and suggest intracellular penetration of the Fab fragments. The dosage of the antibody should be sufficiently high to bind digoxin in the most severe cases of poisoning. The maximum serum concentrations of bound antibody were 30 mg/l after 3 h and 20 mg/l after 5 h. A loading dose of 160 mg followed by an infusion of 0.5 mg/min was sufficient to absorb digoxin re-diffusing into the serum during the first 8 h. In some cases free digoxin reappeared in the serum 8-12 h after beginning the treatment. This might be prevented by infusing a further ampoule at a rate of 0.1 mg/min or less.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>3758140</pmid><doi>10.1007/BF00542410</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6970
ispartof European journal of clinical pharmacology, 1986-01, Vol.30 (5), p.527-533
issn 0031-6970
1432-1041
language eng
recordid cdi_crossref_primary_10_1007_BF00542410
source MEDLINE; SpringerLink (Online service)
subjects Adolescent
Adult
Aged
Animals
Antigen-Antibody Reactions
Biological and medical sciences
Creatinine - blood
Digoxin - immunology
Digoxin - poisoning
Digoxin - urine
Drug intoxications. Doping
Female
Humans
Immunoglobulin Fab Fragments - immunology
Kinetics
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Protein Binding
Sheep
title Kinetics of the fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A48%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kinetics%20of%20the%20fab%20fragments%20of%20digoxin%20antibodies%20and%20of%20bound%20digoxin%20in%20patients%20with%20severe%20digoxin%20intoxication&rft.jtitle=European%20journal%20of%20clinical%20pharmacology&rft.au=SCHAUMANN,%20W&rft.date=1986-01-01&rft.volume=30&rft.issue=5&rft.spage=527&rft.epage=533&rft.pages=527-533&rft.issn=0031-6970&rft.eissn=1432-1041&rft_id=info:doi/10.1007/BF00542410&rft_dat=%3Cpubmed_cross%3E3758140%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/3758140&rfr_iscdi=true